- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04501198
Moxibustion Combined With Characteristic Lifestyle Intervention of Traditional Chinese Medicine in the Treatment of Abdominal Obesity: A Study Protocol for a Randomized Controlled Trial
September 14, 2020 updated by: Wang Jian, Hubei Hospital of Traditional Chinese Medicine
This study will investigate whether the combination of moxibustion and characteristic lifestyle intervention of TCM can alleviate the clinical symptoms and improve quality of life and mental health in patients with abdominal obesity.
The results are expected to provide clinical evidence for the application of the combination of moxibustion and characteristic lifestyle intervention of TCM in patients with abdominal obesity.
Study Overview
Status
Unknown
Conditions
Detailed Description
This study will be a randomized controlled trial conducted from January, 2020 to January, 2022 that includes 150 participants who have abdominal obesity and meet the eligibility criteria.
The participants will be randomly divided into 3 groups in a 2:2:1 allocation ratio.The intervention group will receive moxibustion combined with characteristic lifestyle intervention of TCM;the other group will receive moxibustion combined with lifestyle intervention;the control group will receive lifestyle intervention only.Each treatment will last 12 weeks including 8 weeks of intervention period and 4 weeks of follow-up period.
The primary outcome is the waist circumference(WC),the secondary outcomes include obesity-related indicators,serum biochemical indexs,blood pressure, conversion score of constitution characteristics, and measurement of the scale.Adverse events will be recorded during the intervention and follow-up period.
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Zhongyu Zhou, Professor
- Phone Number: +86 18672308659
- Email: 2209447940@qq.com
Study Contact Backup
- Name: Wei Huang, Professor
- Phone Number: +86 13986083982
- Email: 13986083982@qq.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Patients recruited for this study should meet the following inclusion criteria:
1.Satisfying the criteria for the diagnosis of abdominal obesity; 2.18 years old≤age≤55 years old; 3.Being able to fully understand and voluntarily sign informed consent.
Exclusion Criteria:
Patients with any of the following criteria will be excluded from the study:
- Presence of endocrine disorders such as: polycystic ovary syndrome; Cushing's syndrome; uncorrected thyroid disease.
- Presence of diabetes mellitus, or hypertension, or abnormal liver and kidney functions, or mental diseases.
- Pregnant or lactating state, women who plan to become pregnant within 12 weeks.
- History of bulimia, anorexia, or any other eating disorders.
- Use of medications in the past 3 months, such as diet drugs, corticosteroids, antidepressants, which may affect weight or appetite.
- History of surgical weight loss, postoperative adhesions.
- History of participating in a clinical study of weight loss or any other therapies to lose weight in the past 3 months.
- Presence of local skin rupture, allergy and scar constitution.
- Unable to cooperate with the research caused by other diseases or reasons.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Moxibustion with characteristic lifestyle intervention of TCM
Participants will receive moxibustion combined with characteristic lifestyle intervention of traditional chinese medicine.In this study, xiusheng decoction, traditional exercises, and modern lifestyle intervention will be combined as the characteristic lifestyle intervention method of TCM to help participants establish healthy living habits.
Participants will receive the treatment of moxibustion 6 times a week to fulfill a 8-session treatment course, and the intervention of Xiusheng Decoction and Traditional exercises will last for 8 weeks.While the intervention of modern lifestyle intervention will be conducted for 12 weeks including the treatment period of 8 weeks and the follow-up period of 4 weeks.
|
|
EXPERIMENTAL: moxibustion with lifestyle intervention
Participants will receive moxibustion combined with lifestyle intervention.
Participants will receive the treatment of moxibustion 6 times a week to fulfill a 8-session treatment course,while the intervention of modern lifestyle intervention will be conducted for 12 weeks including the treatment period of 8 weeks and the follow-up period of 4 weeks.
|
|
OTHER: lifestyle intervention
Participants will receive lifestyle intervention which includes modern dietary exercise modifications.
Participants will receive this treatment for a 8-session treatment course and 4-session follow-up course.
|
All patients will be instructed to follow a good living habits including diet and exercise intervention which will last 12 weeks including the treatment period of 8 weeks and the follow-up period of 4 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in waistline
Time Frame: week 0,week 2,week 4,week 6,week 8,week 12
|
Waist circumference will be measured around the abdomen at the level of the umbilicus (belly button).
|
week 0,week 2,week 4,week 6,week 8,week 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in weight
Time Frame: week 0,week 2,week 4,week 6,week 8,week 12
|
Body weight will be measured by a body composition analyzer (OMRON V.BODY).
|
week 0,week 2,week 4,week 6,week 8,week 12
|
Changes in body mass index
Time Frame: week 0,week 2,week 4,week 6,week 8,week 12
|
Body Mass Index is a simple calculation using a person's height and weight.
The formula is BMI = kg/m2 where kg is a person's weight in kilograms and m2 is their height in metres squared.
|
week 0,week 2,week 4,week 6,week 8,week 12
|
Changes in body fat percentage
Time Frame: week 0,week 2,week 4,week 6,week 8,week 12
|
The body fat percentage (BFP) of a human or other living being is the total mass of fat divided by total body mass, multiplied by 100.
Body fat percentage will be measured by a body composition analyzer (OMRON V.BODY).
|
week 0,week 2,week 4,week 6,week 8,week 12
|
Changes in basal metabolic value
Time Frame: week 0,week 2,week 4,week 6,week 8,week 12
|
Basal metabolic value will be measured by a body composition analyzer (OMRON V.BODY).
|
week 0,week 2,week 4,week 6,week 8,week 12
|
Changes in hip circumference
Time Frame: week 0,week 2,week 4,week 6,week 8,week 12
|
hip circumference will be measured at the level of maximum posterior extension of the buttocks.
|
week 0,week 2,week 4,week 6,week 8,week 12
|
Changes in waist-to-hip circumference ratio
Time Frame: week 0,week 2,week 4,week 6,week 8,week 12
|
waist-to-hip ratio is the dimensionless ratio of the circumference of the waist to that of the hips.
This is calculated as waist measurement divided by hip measurement ( W ÷ H ).
|
week 0,week 2,week 4,week 6,week 8,week 12
|
Changes in fasting blood-glucose
Time Frame: week 0, week 8
|
examined with the blood sample
|
week 0, week 8
|
Changes in fasting insulin
Time Frame: week 0, week 8
|
examined with the blood sample
|
week 0, week 8
|
Changes in insulin resistance index insulin resistance index insulin resistance index
Time Frame: week 0, week 8
|
examined with the blood sample
|
week 0, week 8
|
Changes in total cholesterol
Time Frame: week 0, week 8
|
examined with the blood sample
|
week 0, week 8
|
Changes in triglyceride
Time Frame: week 0, week 8
|
examined with the blood sample
|
week 0, week 8
|
Changes in low density lipoprotein
Time Frame: week 0, week 8
|
examined with the blood sample
|
week 0, week 8
|
Changes in high-density lipoprotein
Time Frame: week 0, week 8
|
examined with the blood sample
|
week 0, week 8
|
Changes in uric acid
Time Frame: week 0, week 8
|
examined with the blood sample
|
week 0, week 8
|
Changes in blood pressure
Time Frame: week 0, week 8
|
Both Systolic and diastolic blood pressure assessed by office and ambulatory blood pressure monitoring(mmHg).
|
week 0, week 8
|
Changes in Conversion score of constitution characteristics
Time Frame: week 0, week 8, week 12
|
The scale classification of the patient's constitution according to Traditional Chinese Medicine theory into nine constitutions.
The Constitution in Chinese Medicine Questionnaire (CCMQ) consists of 60 items to classify a person into one or more of nine body constitution types: balanced (8 Items), Qi-deficiency (8 Items), Yang-deficiency (7 Items), Yin-deficiency (8 Items), phlegm-wetness (8 Items), wetness-heat (6 Items), blood-stasis (7 Items), Qi-depression (7 Items), and special diathesis (7 Items).
A higher score in the CCMQ scale indicates a higher likelihood of the specific body constitution.
The original score is sum up each item's score.
The conversion score of constitution characteristics is [(original scores- items)/(items*40]*100.
The balanced constitution is the converted score >60 and the rest constitutions' converted scores all < 30.
The unbalanced constitution is the converted score ≥40.
|
week 0, week 8, week 12
|
Changes in the IWQOL - Lite scale score
Time Frame: week 0, week 8, week 12
|
Quality of life was examined using the Impact of Weight on Quality of Life (IWQOL) Kids questionnaire, which has a score range from 0(worst) to 100(best).
|
week 0, week 8, week 12
|
Changes in the Emotional and Psychological Assessment scale
Time Frame: week 0, week 8, week 12
|
10 item self-report measure of psychological distress with five response categories (none of the time, a little of the time, some of the time, most of the time, all of the time).
Scores range from 10 to 50; a higher score indicates more psychological distress.
|
week 0, week 8, week 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R; Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. Endocr Pract. 2016 Jul;22 Suppl 3:1-203. doi: 10.4158/EP161365.GL. Epub 2016 May 24.
- Tronieri JS, Wadden TA, Walsh OA, Berkowitz RI, Alamuddin N, Gruber K, Leonard S, Chao AM. Effects of liraglutide plus phentermine in adults with obesity following 1 year of treatment by liraglutide alone: A randomized placebo-controlled pilot trial. Metabolism. 2019 Jul;96:83-91. doi: 10.1016/j.metabol.2019.03.005. Epub 2019 Mar 20.
- Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet WB, Billington CJ, Thomas AJ, Leslie DB, Chong K, Jeffery RW, Ahmed L, Vella A, Chuang LM, Bessler M, Sarr MG, Swain JM, Laqua P, Jensen MD, Bantle JP. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA. 2013 Jun 5;309(21):2240-9. doi: 10.1001/jama.2013.5835.
- Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004 Sep 11-17;364(9438):937-52. doi: 10.1016/S0140-6736(04)17018-9.
- Park BY, Lee MJ, Kim M, Kim SH, Park H. Structural and Functional Brain Connectivity Changes Between People With Abdominal and Non-abdominal Obesity and Their Association With Behaviors of Eating Disorders. Front Neurosci. 2018 Oct 11;12:741. doi: 10.3389/fnins.2018.00741. eCollection 2018.
- Freisling H, Arnold M, Soerjomataram I, O'Doherty MG, Ordonez-Mena JM, Bamia C, Kampman E, Leitzmann M, Romieu I, Kee F, Tsilidis K, Tjonneland A, Trichopoulou A, Boffetta P, Benetou V, Bueno-de-Mesquita HBA, Huerta JM, Brenner H, Wilsgaard T, Jenab M. Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of seven prospective cohorts in Europe. Br J Cancer. 2017 May 23;116(11):1486-1497. doi: 10.1038/bjc.2017.106. Epub 2017 Apr 25.
- Dalle Grave R, Calugi S, El Ghoch M. Lifestyle modification in the management of obesity: achievements and challenges. Eat Weight Disord. 2013 Dec;18(4):339-49. doi: 10.1007/s40519-013-0049-4. Epub 2013 Jul 27.
- Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, Loomba R, Camilleri M, Singh S. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis. JAMA. 2016 Jun 14;315(22):2424-34. doi: 10.1001/jama.2016.7602. Erratum In: JAMA. 2016 Sep 6;316(9):995.
- Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, Navaneethan SD, Singh RP, Pothier CE, Nissen SE, Kashyap SR; STAMPEDE Investigators. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 2017 Feb 16;376(7):641-651. doi: 10.1056/NEJMoa1600869.
- Reis LO, Favaro WJ, Barreiro GC, de Oliveira LC, Chaim EA, Fregonesi A, Ferreira U. Erectile dysfunction and hormonal imbalance in morbidly obese male is reversed after gastric bypass surgery: a prospective randomized controlled trial. Int J Androl. 2010 Oct 1;33(5):736-44. doi: 10.1111/j.1365-2605.2009.01017.x. Epub 2009 Dec 16.
- Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, Bucher HC, Nordmann AJ. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013 Oct 22;347:f5934. doi: 10.1136/bmj.f5934.
- Yeh TL, Chen HH, Pai TP, Liu SJ, Wu SL, Sun FJ, Hwang LC. The Effect of Auricular Acupoint Stimulation in Overweight and Obese Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med. 2017;2017:3080547. doi: 10.1155/2017/3080547. Epub 2017 Dec 5.
- Wang LH, Huang W, Zhou W, Zhou L, Zhou XL, Zhou P, Yan Y, Zhou ZY, Wang H. Moxibustion combined with characteristic lifestyle intervention of Traditional Chinese Medicine in the treatment of abdominal obesity: A study protocol for a randomized controlled trial. Medicine (Baltimore). 2020 Oct 23;99(43):e22855. doi: 10.1097/MD.0000000000022855.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
September 1, 2020
Primary Completion (ANTICIPATED)
January 1, 2021
Study Completion (ANTICIPATED)
January 1, 2022
Study Registration Dates
First Submitted
July 23, 2020
First Submitted That Met QC Criteria
August 1, 2020
First Posted (ACTUAL)
August 6, 2020
Study Record Updates
Last Update Posted (ACTUAL)
September 16, 2020
Last Update Submitted That Met QC Criteria
September 14, 2020
Last Verified
September 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202006009
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
the data will be published in the form of public papers before January 2022 for public inquiries
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on moxibustion combined with characteristic lifestyle intervention of traditional chinese medicine
-
Jiangsu Famous Medical Technology Co., Ltd.Completed
-
Seoul National University HospitalCompletedNulliparous Women Who Scheduled for Labor InductionKorea, Republic of
-
Shanghai Mental Health CenterShanghai Center of Biomedicine DevelopmentCompleted
-
Xintian PharmaceuticalCompletedErectile Dysfunction | Chronic Prostatitis With Chronic Pelvic Pain SyndromeChina
-
Xin GaoShanghai Jiao Tong University School of Medicine; Shanghai Municipal Science...CompletedNonalcoholic Fatty Liver DiseaseChina
-
Beijing University of Chinese MedicineRecruitingDegenerative Lumbar Spinal StenosisChina
-
Shijiazhuang Pingan HospitalCompletedAcute Myeloid LeukemiaChina
-
Medical College of WisconsinRecruiting
-
Peking University Third HospitalNot yet recruitingInfertility, Female
-
Alzheimer's Prevention and Reversal Project, Inc.Four Winds FoundationNot yet recruitingMild Cognitive Impairment | Dementia, MildUnited States